The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
| Autor: | A Foundouli, J Vaitsis, P Batika, P Stamatis, T Kelgiorgis, A Basile, H Michalopoulou, E Reinou, D Pragastis, A Bakhal |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2007 |
| Předmět: |
Icu patients
medicine.medical_specialty Septic shock business.industry Levosimendan Critical Care and Intensive Care Medicine medicine.disease Brain natriuretic peptide Intensive care unit Calcium sensitizer law.invention law Internal medicine Heart failure Poster Presentation medicine Cardiology Dobutamine business medicine.drug |
| Zdroj: | Critical Care |
| ISSN: | 1466-609X 1364-8535 |
| Popis: | The brain natriuretic peptide (BNP) is a useful index to follow-up patients with heart failure as well as a special diagnostic and prognostic tool. This study aims at investigating the impact of levosimendan in comparison with dobutamine on the BNP levels in ICU patients with decompensated heart failure related to septic shock. The role of levosimendan in septic patients is still under consideration. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink